Osteogenic Neoplasm — Trials

Osteogenic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

357 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–50 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04616560	Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor	recruiting	Phase 2	55	National Cancer Institute (NCI)NIH	1	Sep 29, 2026	clinicaltrials
NCT04417062	Olaparib With Ceralasertib in Recurrent Osteosarcoma	active not recruiting	Phase 2	49	Dana-Farber Cancer InstituteOTHER	1	Sep 24, 2026	clinicaltrials